KALA BIO
KALA
29 hedge funds and large institutions have $1.58M invested in KALA BIO in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
32% more funds holding
Funds holding: 22 → 29 (+7)
0.08% more ownership
Funds ownership: 0.5% → 0.58% (+0.08%)
41% less capital invested
Capital invested by funds: $2.69M → $1.58M (-$1.11M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$733K |
| 2 |
Jane Street
New York
|
+$129K |
| 3 |
VF
Virtu Financial
New York
|
+$76.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$50.5K |
| 5 |
Renaissance Technologies
New York
|
+$36.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$107K |
| 2 |
MG
Marex Group
London,
|
-$35K |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$20.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.77K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$6.04K |
KALA Hedge Fund Activity: Q4 2025 in Review
29 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2025, worth a combined $1.58M — down 41% from $2.69M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new KALA positions and 4 closed out — a net gain of 7 holders — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $733K. The largest seller was Vanguard Group, cutting an estimated $107K.
- 29 institutional investors held KALA BIO (KALA) as of Q4 2025, up from 22 in Q3 2025.
- Funds reported $1.58M of KALA BIO stock for Q4 2025, down 41% quarter-over-quarter.
- 11 funds opened new KALA BIO positions in Q4 2025 and 4 closed out, a net change of +7 holders.
- The largest KALA BIO buyer in Q4 2025 was Baker Bros. Advisors, an estimated $733K added.
- The largest KALA BIO seller in Q4 2025 was Vanguard Group, an estimated $107K sold.
Based on aggregated 13F filings for Q4 2025.